Artiva Biotherapeutics ARTV
NASDAQ ARTV
$6.34 -0.15 (-2.31%)
As of: Oct 22, 2026 · 1:18 PM EDT

Artiva Biotherapeutics (ARTV) Total Non-Current Liabilities (2023 - 2024)

Updated

Artiva Biotherapeutics' Total Non-Current Liabilities was $22.87 million in Q4 2024, down 90.6% from $242.03 million a year earlier and down 6.8% from the prior quarter.

Analysis

Artiva Biotherapeutics (ARTV) Total Non-Current Liabilities (2023 - 2024) Analysis & Trends

From Q4 2023 onward, Artiva Biotherapeutics has reported Total Non-Current Liabilities for 4 quarters.

  • In earlier years, Total Non-Current Liabilities was $242.03 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,165.98 Bn 1,134.57 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 643.66 Bn 563.53 Bn 17.30 Bn 102.65 Bn
3 AbbVie 500.95 Bn 474.06 Bn 12.70 Bn 106.45 Bn
4 Merck 358.08 Bn 312.45 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 301.84 Bn 265.83 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 267.25 Bn 240.94 Bn 12.86 Bn 33.91 Bn
7 Amgen 241.42 Bn 196.81 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn 35.10 Bn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn 97.04 Bn
10 Artiva Biotherapeutics 248.11 Mn -101.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 22.87 Mn
Sep 30, 2024 24.53 Mn
Jun 30, 2024 239.22 Mn
Dec 31, 2023 241.96 Mn
API Access

Artiva Biotherapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ARTV&period=max&api_key=YOUR_API_KEY